05:46 AM EDT, 06/04/2025 (MT Newswires) -- Basel Medical Group's ( BMGL ) shares were trading down more than 12% in premarket activity Wednesday, heading for another day of volatile price moves despite the company making statements regarding its fundamental underlying strength.

On Tuesday, the company issued a Form 6-K regulatory filing, drawing attention to a press statement from May 29 that reaffirmed the "strength of its underlying financial performance and strategic outlook" despite the recent volatility in its share price.

The company's shares have encountered significant volatility, closing at $1.04 on May 29, $6.08 on May 30, $3.92 on Monday, and $5.09 on Tuesday.

"While recent movements in our share price may raise questions, I want to assure our shareholders and stakeholders that the fundamentals of BMGL remain strong and resilient," Chief Executive Officer Darren Chhoa said in the press statement.

"Our financial performance continues to be robust, with our subsidiaries winning new sizable contracts, particularly in the supply chain, and we remain on track with our acquisition growth strategy," Chhoa added.

Price: 4.44, Change: -0.65, Percent Change: -12.77